Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

71
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
71
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

45
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
45
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

41
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
41
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Updating national diagnostic reference levels for adult cardiac interventional procedures in Switzerland.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Impact of obesity on 1-year major adverse cardiac events after primary PCI for STEMI.

International journal of cardiology·2026
Same author

The Obesity Paradox in Major Adverse Cardiovascular Events After PCI for Acute Coronary Syndrome: A Narrative Review.

Journal of cardiovascular development and disease·2026
Same author

Effect of Nominal-Volume ("Double Tap") Postdilatation on Significant THV Mid-Stent Frame Underexpansion After Balloon-Expandable TAVR.

JACC. Cardiovascular interventions·2026
Same author

Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial.

Circulation·2026
Same author

Murray law-based quantitative flow ratio for functional assessment of coronary lesions: a systematic review and meta-analysis.

The international journal of cardiovascular imaging·2026

関連する実験動画

Updated: Sep 9, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.4K

精神疾患の患者におけるST上昇心筋梗塞の診断と管理の格差

Dorian Garin1, Erik Mendola2, Yannick Faucherre1

  • 1Department of Cardiology, University and Hospital Fribourg, Chem. des Pensionnats 2/6, Fribourg CH-1708, Switzerland.

European heart journal. Quality of care & clinical outcomes
|August 30, 2025
PubMed
まとめ
この要約は機械生成です。

精神疾患 (MHC) の患者は,ST上昇心筋梗塞 (STEMI) の治療に遅延し,より大きな心筋梗塞と心血管疾患のリスクが増加しました. これはMHC患者の緊急心臓治療の格差を強調しています.

キーワード:
心血管に関するアウトカム診断の遅延医療の格差精神的健康についてSTEMI

さらに関連する動画

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

関連する実験動画

Last Updated: Sep 9, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.4K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.6K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

科学分野:

  • 心臓病科
  • 精神科
  • 公衆衛生

背景:

  • 精神疾患 (MHC) の患者は,診断と治療に遅延することが多い.
  • 専用のST上昇心筋梗塞 (STEMI) 速攻プロトコルは,これらの重要な心疾患の治療を早めることを目的としています.

研究 の 目的:

  • STEMI 急速治療のプロトコルにもかかわらず,MHC の患者がより長い治療遅延とより悪い結果を経験するかどうかを評価する.
  • STEMI患者におけるMHCに関連した特定の遅延および有害事象を特定する.

主な方法:

  • STEMI患者の将来的なEVALFASTレジストラの分析
  • STEMI診断時に記録されたMHCに基づいて,MHCコホートに患者の分類.
  • 一般化された線形モデルとコックスの回帰を用いた統計的分析.

主要な成果:

  • MHC患者 (12. 1%) は,プロトコルにもかかわらず,診断までの最初の医療接触 (FMC) (+16. 4分) と,FMCから気球までの時間 (+18. 6分) が長かった.
  • MHCコホートは,より大きな心筋梗塞のサイズ (ピークCK- MB+71. 3U/ L) と,30日間のMACCE (aHR1. 82) と5年後の心血管死 (aHR2. 04) のリスクの増加を示した.
  • 遅延は緊急治療室に自己紹介した患者でより顕著でした.

結論:

  • STEMI患者におけるMHCは,迅速なプロトコルに関係なく,早期治療に重大な遅延が伴う.
  • これらの遅延は心臓発作の大きさに寄与し,短期的および長期的不良心血管疾患のリスクを高めます.
  • 精神疾患はSTEMIの適時かつ効果的な治療に障壁となり,長期的な心血管疾患に影響を及ぼします.